Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz will increase production up to 220 trucks per day

2/19/24 KMAZ

Polymetal postpones dividend decision until May for now

2/19/24 POLY

UGC will free up more than 40 tons of gold for mining

2/19/24 UGLD

Fix Price's operating subsidiary reported by RAS

2/19/24 FIXP

M&A deals of Mosgorlombard will be financed by Promsvyazbank

2/19/24 MGKL

M.Video attracts strangers to its service areas

2/19/24 MVID

Kamaz cedes leadership to China's Sitrak

2/19/24 KMAZ

Polymetal agreed to sell Russian assets

2/19/24 POLY

Sovcombank will allocate 30% of 2023 profit for dividends

2/16/24 SVCB

Uralsib bailout completed ahead of schedule

2/16/24 USBN